Hatch-Waxman Hatch-Waxman 40th anniversary acknowledged by the AAM, Biosimilars Council , and Chain Drug Review September 24, 2024
Association for Accessible Medicines Generic and biosimilar medicines saved patients and industry $445 billion, report says , and Chain Drug Review September 5, 2024
